COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Rinn Song
Institution
University of Oxford
Address
Oxford
United Kingdom
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2007
1
2011
1
2015
1
2017
1
2018
1
2019
1
2020
4
2021
4
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Barrett JR
,
Belij-Rammerstorfer S
,
Dold C
,
Ewer KJ
,
Folegatti PM
,
Gilbride C
,
Halkerston R
,
Hill J
,
Jenkin D
,
Stockdale L
,
Verheul MK
,
Aley PK
,
Angus B
,
Bellamy D
,
Berrie E
,
Bibi S
,
Bittaye M
,
Carroll MW
,
Cavell B
,
Clutterbuck EA
,
Edwards N
,
Flaxman A
,
Fuskova M
,
Gorringe A
,
Hallis B
,
Kerridge S
,
Lawrie AM
,
Linder A
,
Liu X
,
Madhavan M
,
Makinson R
,
Mellors J
,
Minassian A
,
Moore M
,
Mujadidi Y
,
Plested E
,
Poulton I
,
Ramasamy MN
,
Robinson H
,
Rollier CS
,
Song R
,
Snape MD
,
Tarrant R
,
Taylor S
,
Thomas KM
,
Voysey M
,
Watson MEE
,
Wright D
,
Douglas AD
,
Green CM
,
Hill AVS
,
Lambe T
,
Gilbert S
,
Pollard AJ
. Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021 Jun; 27(6):1113.
PMID:
33958800
.
Citations:
1
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Ewer KJ
,
Barrett JR
,
Belij-Rammerstorfer S
,
Sharpe H
,
Makinson R
,
Morter R
,
Flaxman A
,
Wright D
,
Bellamy D
,
Bittaye M
,
Dold C
,
Provine NM
,
Aboagye J
,
Fowler J
,
Silk SE
,
Alderson J
,
Aley PK
,
Angus B
,
Berrie E
,
Bibi S
,
Cicconi P
,
Clutterbuck EA
,
Chelysheva I
,
Folegatti PM
,
Fuskova M
,
Green CM
,
Jenkin D
,
Kerridge S
,
Lawrie A
,
Minassian AM
,
Moore M
,
Mujadidi Y
,
Plested E
,
Poulton I
,
Ramasamy MN
,
Robinson H
,
Song R
,
Snape MD
,
Tarrant R
,
Voysey M
,
Watson MEE
,
Douglas AD
,
Hill AVS
,
Gilbert SC
,
Pollard AJ
,
Lambe T
. Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2021 Jun; 27(6):1116.
PMID:
34021278
.
Citations:
1
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Emary KRW
,
Golubchik T
,
Aley PK
,
Ariani CV
,
Angus B
,
Bibi S
,
Blane B
,
Bonsall D
,
Cicconi P
,
Charlton S
,
Clutterbuck EA
,
Collins AM
,
Cox T
,
Darton TC
,
Dold C
,
Douglas AD
,
Duncan CJA
,
Ewer KJ
,
Flaxman AL
,
Faust SN
,
Ferreira DM
,
Feng S
,
Finn A
,
Folegatti PM
,
Fuskova M
,
Galiza E
,
Goodman AL
,
Green CM
,
Green CA
,
Greenland M
,
Hallis B
,
Heath PT
,
Hay J
,
Hill HC
,
Jenkin D
,
Kerridge S
,
Lazarus R
,
Libri V
,
Lillie PJ
,
Ludden C
,
Marchevsky NG
,
Minassian AM
,
McGregor AC
,
Mujadidi YF
,
Phillips DJ
,
Plested E
,
Pollock KM
,
Robinson H
,
Smith A
,
Song R
,
Snape MD
,
Sutherland RK
,
Thomson EC
,
Toshner M
,
Turner DPJ
,
Vekemans J
,
Villafana TL
,
Williams CJ
,
Hill AVS
,
Lambe T
,
Gilbert SC
, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021 04 10; 397(10282):1351-1362.
PMID:
33798499
.
Citations:
144
Fields:
Med
Medicine (General)
Translation:
Humans
PH
Public Health
CT
Clinical Trials
Voysey M
,
Costa Clemens SA
,
Madhi SA
,
Weckx LY
,
Folegatti PM
,
Aley PK
,
Angus B
,
Baillie VL
,
Barnabas SL
,
Bhorat QE
,
Bibi S
,
Briner C
,
Cicconi P
,
Clutterbuck EA
,
Collins AM
,
Cutland CL
,
Darton TC
,
Dheda K
,
Dold C
,
Duncan CJA
,
Emary KRW
,
Ewer KJ
,
Flaxman A
,
Fairlie L
,
Faust SN
,
Feng S
,
Ferreira DM
,
Finn A
,
Galiza E
,
Goodman AL
,
Green CM
,
Green CA
,
Greenland M
,
Hill C
,
Hill HC
,
Hirsch I
,
Izu A
,
Jenkin D
,
Joe CCD
,
Kerridge S
,
Koen A
,
Kwatra G
,
Lazarus R
,
Libri V
,
Lillie PJ
,
Marchevsky NG
,
Marshall RP
,
Mendes AVA
,
Milan EP
,
Minassian AM
,
McGregor A
,
Mujadidi YF
,
Nana A
,
Padayachee SD
,
Phillips DJ
,
Pittella A
,
Plested E
,
Pollock KM
,
Ramasamy MN
,
Ritchie AJ
, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
PMID:
33617777
.
Citations:
222
Fields:
Med
Medicine (General)
Translation:
Humans
Barrett JR
,
Belij-Rammerstorfer S
,
Dold C
,
Ewer KJ
,
Folegatti PM
,
Gilbride C
,
Halkerston R
,
Hill J
,
Jenkin D
,
Stockdale L
,
Verheul MK
,
Aley PK
,
Angus B
,
Bellamy D
,
Berrie E
,
Bibi S
,
Bittaye M
,
Carroll MW
,
Cavell B
,
Clutterbuck EA
,
Edwards N
,
Flaxman A
,
Fuskova M
,
Gorringe A
,
Hallis B
,
Kerridge S
,
Lawrie AM
,
Linder A
,
Liu X
,
Madhavan M
,
Makinson R
,
Mellors J
,
Minassian A
,
Moore M
,
Mujadidi Y
,
Plested E
,
Poulton I
,
Ramasamy MN
,
Robinson H
,
Rollier CS
,
Song R
,
Snape MD
,
Tarrant R
,
Taylor S
,
Thomas KM
,
Voysey M
,
Watson MEE
,
Wright D
,
Douglas AD
,
Green CM
,
Hill AVS
,
Lambe T
,
Gilbert S
,
Pollard AJ
. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021 02; 27(2):279-288.
PMID:
33335322
.
Citations:
65
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
CT
Clinical Trials
Ewer KJ
,
Barrett JR
,
Belij-Rammerstorfer S
,
Sharpe H
,
Makinson R
,
Morter R
,
Flaxman A
,
Wright D
,
Bellamy D
,
Bittaye M
,
Dold C
,
Provine NM
,
Aboagye J
,
Fowler J
,
Silk SE
,
Alderson J
,
Aley PK
,
Angus B
,
Berrie E
,
Bibi S
,
Cicconi P
,
Clutterbuck EA
,
Chelysheva I
,
Folegatti PM
,
Fuskova M
,
Green CM
,
Jenkin D
,
Kerridge S
,
Lawrie A
,
Minassian AM
,
Moore M
,
Mujadidi Y
,
Plested E
,
Poulton I
,
Ramasamy MN
,
Robinson H
,
Song R
,
Snape MD
,
Tarrant R
,
Voysey M
,
Watson MEE
,
Douglas AD
,
Hill AVS
,
Gilbert SC
,
Pollard AJ
,
Lambe T
. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2021 02; 27(2):270-278.
PMID:
33335323
.
Citations:
102
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
Cells
PH
Public Health
CT
Clinical Trials
Voysey M
, Clemens SAC,
Madhi SA
,
Weckx LY
,
Folegatti PM
,
Aley PK
,
Angus B
,
Baillie VL
,
Barnabas SL
,
Bhorat QE
,
Bibi S
,
Briner C
,
Cicconi P
,
Collins AM
,
Colin-Jones R
,
Cutland CL
,
Darton TC
,
Dheda K
,
Duncan CJA
,
Emary KRW
,
Ewer KJ
,
Fairlie L
,
Faust SN
,
Feng S
,
Ferreira DM
,
Finn A
,
Goodman AL
,
Green CM
,
Green CA
,
Heath PT
,
Hill C
,
Hill H
,
Hirsch I
,
Hodgson SHC
,
Izu A
,
Jackson S
,
Jenkin D
,
Joe CCD
,
Kerridge S
,
Koen A
,
Kwatra G
,
Lazarus R
,
Lawrie AM
,
Lelliott A
,
Libri V
,
Lillie PJ
,
Mallory R
,
Mendes AVA
,
Milan EP
,
Minassian AM
,
McGregor A
,
Morrison H
,
Mujadidi YF
,
Nana A
,
O'Reilly PJ
,
Padayachee SD
,
Pittella A
,
Plested E
,
Pollock KM
,
Ramasamy MN
,
Rhead S
, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
PMID:
33306989
.
Citations:
956
Fields:
Med
Medicine (General)
Translation:
Humans
Ramasamy MN
,
Minassian AM
,
Ewer KJ
,
Flaxman AL
,
Folegatti PM
,
Owens DR
,
Voysey M
,
Aley PK
,
Angus B
,
Babbage G
,
Belij-Rammerstorfer S
,
Berry L
,
Bibi S
,
Bittaye M
,
Cathie K
,
Chappell H
,
Charlton S
,
Cicconi P
,
Clutterbuck EA
,
Colin-Jones R
,
Dold C
,
Emary KRW
,
Fedosyuk S
,
Fuskova M
,
Gbesemete D
,
Green C
,
Hallis B
,
Hou MM
,
Jenkin D
,
Joe CCD
,
Kelly EJ
,
Kerridge S
,
Lawrie AM
,
Lelliott A
,
Lwin MN
,
Makinson R
,
Marchevsky NG
,
Mujadidi Y
,
Munro APS
,
Pacurar M
,
Plested E
,
Rand J
,
Rawlinson T
,
Rhead S
,
Robinson H
,
Ritchie AJ
,
Ross-Russell AL
,
Saich S
,
Singh N
,
Smith CC
,
Snape MD
,
Song R
,
Tarrant R
,
Themistocleous Y
,
Thomas KM
,
Villafana TL
,
Warren SC
,
Watson MEE
,
Douglas AD
,
Hill AVS
,
Lambe T
, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021 12 19; 396(10267):1979-1993.
PMID:
33220855
.
Citations:
321
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs